ReviewJournal of Cancer2017

Surveilling the Potential for Precision Medicine-driven PD-1/PD-L1-targeted Therapy in HNSCC.

J E Mann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.